MA-GENOMETRY
GENOMETRY, INC. today announced entering into a service agreement with JANSSEN PHARMACEUTICA NV of Beerse, Belgium under the terms of which Genometry will generate gene-expression profiles from 250,000 compounds from Janssen’s small-molecule screening library using its proprietary L1000™ Expression Profiling technology. This is the first time gene-expression profiling has been applied at this scale, and this multi-year contract showcases a commitment to high-throughput gene-expression profiling for multiple drug discovery and development applications. The data will be used for primary screening and library characterization as well as to improve the selection of candidate drugs prior to clinical studies.
“L1000 was developed to make gene-expression profiling experiments of unprecedented scale and scope possible, and Genometry was founded to get this transformative technology into the hands of professional drug developers,” said Justin Lamb, Ph.D., Genometry’s President and CEO. “We are therefore thrilled to see Janssen engage in a true library-scale profiling effort uniquely enabled by Genometry’s capabilities.”
About Genometry
GENOMETRY, INC. is a life-science platform-technology company commercializing and popularizing a revolutionary high-throughput gene-expression profiling method for next-generation pharmaceutical discovery applications. L1000™ Expression Profiling produces gene-expression profiles at a rate of thousands a day and at only a fraction of the cost of conventional methods, enabling the use of expression profiling at a scale never before possible. GENOMETRY, INC. is the sole and exclusive provider of commercial gene-expression profiling services using L1000, and offers data-generation solutions and tailored expert support to the pharmaceutical, biotechnology, personal care, and consumer products industries from headquarters in Kendall Square, Cambridge MA and satellite facilities worldwide. More information is available at www.genometry.com or from info@genometry.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20151007006618/en/
Contact:
Media:
BrewLife
Christiana Pascale, 212-257-6722
cpascale@w2ogroup.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BGO Announces US$5.1 Billion Capital Raise for Its Asia Value-Add Real Estate Strategy, Marking Largest Closed-End Fundraise in Firm’s History5.6.2025 22:00:00 CEST | Press release
BGO today announced the final close of BentallGreenOak Asia IV (“BGO Asia Fund IV” or the “Fund”), its flagship Asia-focused value-add real estate strategy, raising over US$5.1 billion in total capital commitments for the Fund and co-investment sidecars. The Fund represents the largest closed-end capital raise in BGO’s history, underscoring the firm’s history and reputation as a premier global real estate investment manager in Asian markets. BGO Asia Fund IV targets value-add opportunities in office, hospitality, and logistics assets across Japan, South Korea, Australia, and Singapore. Japan represents a central pillar of our investment strategy, driven by regulatory reforms and corporate governance shifts that are catalyzing an estimated US$3 trillion in non-core asset divestitures. “Japan is undergoing a profound transformation, and we see strong, sustained tailwinds across the region,” said Fred Schmidt, Managing Partner and Chairman of Asia, BGO. “Tokyo is one of the world’s larges
PIF and FIFA forge partnership for FIFA Club World Cup 2025™5.6.2025 19:00:00 CEST | Press release
PIF joins inaugural FIFA Club World Cup™ ahead of kick-off on June 14 in Miami The partnership expands PIF’s global footprint in sports and reflects a shared commitment with FIFA to fuel growth and engagement in football FIFA Club World Cup 2025™ will make history, redefining club football and bringing 32 of the world’s best clubs together for the first time PIF and FIFA today announced PIF as an official partner of FIFA Club World Cup 2025™, which will take place in the U.S. from June 14 to July 13, 2025. The partnership reflects FIFA and PIF’s shared vision to enable greater participation in sports by unlocking new opportunities, fostering innovation and engaging fans around the world. With a focus on youth, the partnership will provide opportunities for young people, supporting FIFA in its efforts to engage and inspire at a grassroots level. The new FIFA Club World Cup 2025™ marks a fresh chapter for club football on the global stage. It will feature 32 of the world’s top football c
Orange Logic Appoints Ben Colenso as Managing Director, EMEA5.6.2025 18:41:00 CEST | Press release
Strategic hire underscores company’s growth and commitment to the region Orange Logic, the leader in digital asset management and content orchestration, today announced the appointment of Ben Colenso as Managing Director for EMEA. Based in the UK, Colenso will spearhead Orange Logic’s regional strategy, customer enablement, and market expansion efforts, as the company accelerates its global footprint. Colenso brings 20 years of experience in technology and media production, having most recently led the technology strategy for Hogarth, WPP’s content experience company. Known for solving complex problems for some of the world’s most iconic brands with his customer-centric approach, Colenso will play a critical role in strengthening Orange Logic’s presence and partnerships across EMEA which span customers such as ITV, Pearson, GSK, Ubisoft and Tourism Ireland amongst others. “Ben’s appointment reflects our deep commitment to EMEA, where we continue to see strong momentum and increasing de
Rimini Street Announces the Extension of Support for All SAP ECC 6.0 and S/4HANA Releases Through 20405.6.2025 17:22:00 CEST | Press release
All SAP software licensees can now easily extend the useful life and maximize the full value of their current, proven and stable mission-critical systems and enjoy total maintenance savings of up to 90% without the requirement of a costly and risky migration to S/4HANA on RISE Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced it has extended full support coverage for all SAP ECC 6.0 and S/4HANA releases through 2040, without any need to complete a migration to S/4HANA on RISE as required by SAP for clients who want to remain on SAP’s Annual Support and receive full support. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250605581964/en/ Rimini Street Announces the Extension of Support for All SAP ECC 6.0 and S/4HANA Releases Through 2040 Rimini S
Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR Platform5.6.2025 16:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™fully human antibody mouse platform has been granted an invention patent by the Japan Patent Office (JPO). This milestone marks a significant step in strengthening the global intellectual property portfolio of the RenMice® fully human antibody platform family. It underscores the continued advancement of Biocytogen’s comprehensive global patent strategy and highlights the innovation and international recognition of the company’s proprietary technologies. RenMab™ mice are a core member of Biocytogen’s independently developed RenMice® fully human antibody discovery platform family. Using Biocytogen’s proprietary Size-Unlimited and Precise Chromosome Engineering (SUPCE®) technology, the complete repertoire of murine immunoglobulin heavy chain and light chain variable region genes was precisely replaced in situ with their human counterparts.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom